1. Home
  2. TTSH vs AKBA Comparison

TTSH vs AKBA Comparison

Compare TTSH & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTSH
  • AKBA
  • Stock Information
  • Founded
  • TTSH 1985
  • AKBA 2007
  • Country
  • TTSH United States
  • AKBA United States
  • Employees
  • TTSH N/A
  • AKBA N/A
  • Industry
  • TTSH Blank Checks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TTSH Finance
  • AKBA Health Care
  • Exchange
  • TTSH Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • TTSH 295.2M
  • AKBA 336.2M
  • IPO Year
  • TTSH N/A
  • AKBA 2014
  • Fundamental
  • Price
  • TTSH $6.89
  • AKBA $1.88
  • Analyst Decision
  • TTSH
  • AKBA Strong Buy
  • Analyst Count
  • TTSH 0
  • AKBA 1
  • Target Price
  • TTSH N/A
  • AKBA $7.50
  • AVG Volume (30 Days)
  • TTSH 90.9K
  • AKBA 2.0M
  • Earning Date
  • TTSH 11-07-2024
  • AKBA 11-07-2024
  • Dividend Yield
  • TTSH N/A
  • AKBA N/A
  • EPS Growth
  • TTSH N/A
  • AKBA N/A
  • EPS
  • TTSH 0.08
  • AKBA N/A
  • Revenue
  • TTSH $352,075,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • TTSH $8.17
  • AKBA N/A
  • Revenue Next Year
  • TTSH N/A
  • AKBA $30.85
  • P/E Ratio
  • TTSH $85.58
  • AKBA N/A
  • Revenue Growth
  • TTSH N/A
  • AKBA N/A
  • 52 Week Low
  • TTSH $5.68
  • AKBA $0.80
  • 52 Week High
  • TTSH $7.67
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • TTSH 58.63
  • AKBA 50.78
  • Support Level
  • TTSH $6.74
  • AKBA $1.79
  • Resistance Level
  • TTSH $7.02
  • AKBA $1.90
  • Average True Range (ATR)
  • TTSH 0.18
  • AKBA 0.08
  • MACD
  • TTSH 0.02
  • AKBA -0.03
  • Stochastic Oscillator
  • TTSH 77.05
  • AKBA 28.95

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: